Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism OX2R antagonists(Orexin receptor type 2 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Sleep Initiation and Maintenance Disorders | Phase 1 | CN | 13 May 2024 | |
Sleep Initiation and Maintenance Disorders | Phase 1 | CN | 13 May 2024 |